Literature DB >> 10478652

Increased cytokine release from peripheral blood cells after acute stroke.

C Ferrarese1, P Mascarucci, C Zoia, R Cavarretta, M Frigo, B Begni, F Sarinella, L Frattola, M G De Simoni.   

Abstract

Cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha can play pathogenetic or protective roles in stroke. They are increased in the brain after experimental ischemia and in the CSF of patients with stroke. However, their presence in the periphery is still controversial. To determine the source and time-course of cytokines in blood of stroke patients, IL-6 and TNF-alpha release from blood cells and serum levels were determined in 40 patients on days 1 through 2, 4, 10, 30, and 90 after stroke. Twenty healthy age-matched volunteers were used as controls. IL-6 and TNF-alpha release from stimulated blood cells was increased in stroke patients, compared to controls. A peak response (+224%) was observed at day 4 for IL-6, while TNF-alpha release was largely and significantly increased (about three-fold compared to controls) from day 1 to 2 until day 90 after stroke. The increase in IL-6 release was significantly higher in ischemic, compared to hemorrhagic strokes, at days 1 and 4. Circulating IL-6 was increased at each time point. The ischemic processes in the CNS induces a long-lasting activation of IL-6 and TNF-alpha production in peripheral blood cells, which are a major source of serum cytokines after stroke.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10478652     DOI: 10.1097/00004647-199909000-00008

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  59 in total

Review 1.  Inflammation and Stroke: An Overview.

Authors:  Josef Anrather; Costantino Iadecola
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 2.  Inflammatory cytokines in experimental and human stroke.

Authors:  Kate Lykke Lambertsen; Knut Biber; Bente Finsen
Journal:  J Cereb Blood Flow Metab       Date:  2012-06-27       Impact factor: 6.200

Review 3.  Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets.

Authors:  Danielle N Doll; Taura L Barr; James W Simpkins
Journal:  Aging Dis       Date:  2014-10-01       Impact factor: 6.745

4.  Activation of immune responses to brain antigens after stroke.

Authors:  Kyra J Becker
Journal:  J Neurochem       Date:  2012-11       Impact factor: 5.372

5.  The apoptotic actions of platelets in acute ischemic stroke.

Authors:  Ozge Cevik; Zelal Adiguzel; Ahmet Tarik Baykal; Goksel Somay; Azize Sener
Journal:  Mol Biol Rep       Date:  2013-09-22       Impact factor: 2.316

6.  Acute stroke patients are being underfed: a nitrogen balance study.

Authors:  Julio A Chalela; Joseph Haymore; Peter D Schellinger; Dong-Wha Kang; Steven Warach
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

7.  Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients.

Authors:  Tomasz Dziedzic; Elzbieta A Gryz; Wojciech Turaj; Agnieszka Slowik; Andrzej Szczudlik
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  Serum interleukin-6 predicts cortisol release in acute stroke patients.

Authors:  A Szczudlik; T Dziedzic; S Bartus; A Slowik; A Kieltyka
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

Review 9.  Inflammatory mechanisms in ischemic stroke: therapeutic approaches.

Authors:  Shaheen E Lakhan; Annette Kirchgessner; Magdalena Hofer
Journal:  J Transl Med       Date:  2009-11-17       Impact factor: 5.531

10.  Vulnerability to stroke: implications of perinatal programming of the hypothalamic-pituitary-adrenal axis.

Authors:  Tara K S Craft; A Courtney Devries
Journal:  Front Behav Neurosci       Date:  2009-12-09       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.